Cargando…

Validation of a method to assess emphysema severity by spirometry in the COPDGene study

BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) cu...

Descripción completa

Detalles Bibliográficos
Autores principales: Occhipinti, Mariaelena, Paoletti, Matteo, Crapo, James D., Make, Barry J., Lynch, David A., Brusasco, Vito, Lavorini, Federico, Silverman, Edwin K., Regan, Elizabeth A., Pistolesi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195744/
https://www.ncbi.nlm.nih.gov/pubmed/32357885
http://dx.doi.org/10.1186/s12931-020-01366-4
_version_ 1783528600016781312
author Occhipinti, Mariaelena
Paoletti, Matteo
Crapo, James D.
Make, Barry J.
Lynch, David A.
Brusasco, Vito
Lavorini, Federico
Silverman, Edwin K.
Regan, Elizabeth A.
Pistolesi, Massimo
author_facet Occhipinti, Mariaelena
Paoletti, Matteo
Crapo, James D.
Make, Barry J.
Lynch, David A.
Brusasco, Vito
Lavorini, Federico
Silverman, Edwin K.
Regan, Elizabeth A.
Pistolesi, Massimo
author_sort Occhipinti, Mariaelena
collection PubMed
description BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) curve in standard spirometry. METHODS: From the COPDGene population we selected those 5930 subjects with MEFV curve and inspiratory-expiratory CT obtained on the same day. The MEFV curve descending limb was fit real-time using forced vital capacity (FVC), peak expiratory flow, and forced expiratory flows at 25, 50 and 75% of FVC to derive an emphysema severity index (ESI), expressed as a continuous positive numeric parameter ranging from 0 to 10. According to inspiratory CT percent lung attenuation area below − 950 HU we defined three emphysema severity subgroups (%LAA(-950insp) < 6, 6–14, ≥14). By co-registration of inspiratory-expiratory CT we quantified persistent (%pLDA) and functional (%fLDA) low-density areas as CT metrics of emphysema and airway disease, respectively. RESULTS: ESI differentiated CT emphysema severity subgroups increasing in parallel with GOLD stages (p < .001), but with high variability within each stage. ESI had significantly higher correlations (p < .001) with emphysema than with airway disease CT metrics, explaining 67% of %pLDA variability. Conversely, standard spirometric variables (FEV(1), FEV(1)/FVC) had significantly lower correlations than ESI with emphysema CT metrics and did not differentiate between emphysema and airways CT metrics. CONCLUSIONS: ESI adds to standard spirometry the power to discriminate whether emphysema is the predominant mechanism of airway obstruction. ESI methodology has been validated in the large multiethnic population of smokers of the COPDGene study and therefore it could be applied for clinical and research purposes in the general population of smokers, using a readily available online website.
format Online
Article
Text
id pubmed-7195744
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-71957442020-05-06 Validation of a method to assess emphysema severity by spirometry in the COPDGene study Occhipinti, Mariaelena Paoletti, Matteo Crapo, James D. Make, Barry J. Lynch, David A. Brusasco, Vito Lavorini, Federico Silverman, Edwin K. Regan, Elizabeth A. Pistolesi, Massimo Respir Res Research BACKGROUND: Standard spirometry cannot identify the predominant mechanism underlying airflow obstruction in COPD, namely emphysema or airway disease. We aimed at validating a previously developed methodology to detect emphysema by mathematical analysis of the maximal expiratory flow-volume (MEFV) curve in standard spirometry. METHODS: From the COPDGene population we selected those 5930 subjects with MEFV curve and inspiratory-expiratory CT obtained on the same day. The MEFV curve descending limb was fit real-time using forced vital capacity (FVC), peak expiratory flow, and forced expiratory flows at 25, 50 and 75% of FVC to derive an emphysema severity index (ESI), expressed as a continuous positive numeric parameter ranging from 0 to 10. According to inspiratory CT percent lung attenuation area below − 950 HU we defined three emphysema severity subgroups (%LAA(-950insp) < 6, 6–14, ≥14). By co-registration of inspiratory-expiratory CT we quantified persistent (%pLDA) and functional (%fLDA) low-density areas as CT metrics of emphysema and airway disease, respectively. RESULTS: ESI differentiated CT emphysema severity subgroups increasing in parallel with GOLD stages (p < .001), but with high variability within each stage. ESI had significantly higher correlations (p < .001) with emphysema than with airway disease CT metrics, explaining 67% of %pLDA variability. Conversely, standard spirometric variables (FEV(1), FEV(1)/FVC) had significantly lower correlations than ESI with emphysema CT metrics and did not differentiate between emphysema and airways CT metrics. CONCLUSIONS: ESI adds to standard spirometry the power to discriminate whether emphysema is the predominant mechanism of airway obstruction. ESI methodology has been validated in the large multiethnic population of smokers of the COPDGene study and therefore it could be applied for clinical and research purposes in the general population of smokers, using a readily available online website. BioMed Central 2020-05-01 2020 /pmc/articles/PMC7195744/ /pubmed/32357885 http://dx.doi.org/10.1186/s12931-020-01366-4 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Occhipinti, Mariaelena
Paoletti, Matteo
Crapo, James D.
Make, Barry J.
Lynch, David A.
Brusasco, Vito
Lavorini, Federico
Silverman, Edwin K.
Regan, Elizabeth A.
Pistolesi, Massimo
Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title_full Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title_fullStr Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title_full_unstemmed Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title_short Validation of a method to assess emphysema severity by spirometry in the COPDGene study
title_sort validation of a method to assess emphysema severity by spirometry in the copdgene study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7195744/
https://www.ncbi.nlm.nih.gov/pubmed/32357885
http://dx.doi.org/10.1186/s12931-020-01366-4
work_keys_str_mv AT occhipintimariaelena validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT paolettimatteo validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT crapojamesd validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT makebarryj validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT lynchdavida validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT brusascovito validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT lavorinifederico validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT silvermanedwink validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT reganelizabetha validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy
AT pistolesimassimo validationofamethodtoassessemphysemaseveritybyspirometryinthecopdgenestudy